Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News MetaStat Inc MTST

Healthcare Technology Biotechnology Scientific & Technical Instruments

MetaStat, Inc. is a precision medicine company. The Company's therapeutic focus targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. The Company's product development programs are focused on developing drug candidates and companion diagnostic tests that target the MENA pathway. Its pipelines include MENA Diagnostic... see more

Add To Watchlist

Recent & Breaking News (GREY:MTST)

MetaStat Appoints Jerome B. Zeldis, M.D., Ph.D. to its Board of Directors

Business Wire April 27, 2016

MetaStat Announces Successful Analytical Validation of its MenaCalc(TM) Cancer Diagnostic Platform

Business Wire January 26, 2016

MetaStat Presents Positive Analytical Validation Data for MetaSite Breast(TM) Cancer Diagnostic Test

Business Wire December 2, 2015

MetaStat Receives CLIA Certification from the Centers for Medicare and Medicaid Services

Business Wire November 30, 2015

MetaStat Announces Reverse Stock Split in Preparation for a Proposed Uplisting to a National Market

Business Wire October 7, 2015

Benchmark Securities Initiates Coverage of MetaStat, Inc. with a Speculative Buy Rating

Accesswire October 6, 2015

Zacks Small-Cap Research: "MTST: Lab Receives State License, Last Major Before CLIA Certification"

Accesswire September 29, 2015

MetaStat Receives Massachusetts State Clinical Laboratory License

Business Wire September 28, 2015

MetaStat Announces Positive Topline Results of a MetaSite Breast(TM) Prognostic Study in Invasive Breast Cancer

Marketwired September 23, 2015

Award Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board

Marketwired September 10, 2015

MetaStat, Inc. Announces Positive Results of a MenaCalc(TM) Prognostic Study of Axillary Node-Negative Breast Cancer

Marketwired September 2, 2015

MetaStat Announces Successful Analytical Validation of its MetaSite Breast(TM) Cancer Diagnostic

Business Wire August 27, 2015

MetaStat, Inc. Appoints Michael J. Donovan, PhD, MD as Chief Medical Officer

Business Wire August 17, 2015

MetaStat Raises Additional Capital in Private Placement

Business Wire August 5, 2015

SeeThruEquity Initiates Coverage on MetaStat, Inc. with a Price Target of $1.23

Accesswire June 25, 2015

MetaStat Shareholders Approve Reverse Stock Split

Business Wire June 23, 2015

MetaStat, Inc. Announces Douglas A. Hamilton Named President, Chief Executive Officer

Business Wire June 18, 2015

MetaStat To Present at SeeThruEquity Conference in New York City on May 28

Accesswire May 20, 2015

MetaStat To Present at SeeThruEquity Conference in New York City on May 28

Accesswire May 20, 2015

MetaStat Demonstrates MenaCalc Lung(TM) Is Prognostic for Outcome in Non-Small Cell Lung Cancer

Business Wire April 21, 2015